Literature DB >> 10436233

Resection of hepatic metastases of colorectal carcinoma: 20 years' experience.

S Nakamura1, S Suzuki, H Konno.   

Abstract

We analyzed the results and the prognostic factors influencing survival in 79 patients with metastases of colorectal carcinoma who underwent hepatectomy at our hospital in the 20-year period 1978-1998. The 5- and 10-year survival rates were 49% and 33%, respectively. Repeat hepatectomy was done 29 times in 24 patients with relapse of liver tumors. The 3- and 5-year survival rates after repeat hepatectomy were 58% and 14%, respectively. The distribution of and number of tumors in the liver, the disease-free interval from initial to second hepatectomy, and the presence of extrahepatic disease were significantly associated with survival (P < 0.01). Seven of 43 patients who underwent hilar node dissection had metastasis and 2 of them survived for more than 5 years. Repeat hepatectomy and hilar lymphadenectomy may be effective in prolonging the survival of selected patients with hepatic metastasis. We also discuss prognostic factors after extensive surgery for hepatic metastases of colorectal carcinoma.

Entities:  

Mesh:

Year:  1999        PMID: 10436233     DOI: 10.1007/s005340050079

Source DB:  PubMed          Journal:  J Hepatobiliary Pancreat Surg        ISSN: 0944-1166


  22 in total

1.  Resection of non-hepatic colorectal cancer metastasis.

Authors:  Fabian M Johnston; Peter J Kneuertz; Timothy M Pawlik
Journal:  J Gastrointest Oncol       Date:  2012-03

2.  Resection margin with anatomic or nonanatomic hepatectomy for liver metastasis from colorectal cancer.

Authors:  Yoshihiro Inoue; Michihiro Hayashi; Koji Komeda; Shinsuke Masubuchi; Masashi Yamamoto; Hidenori Yamana; Hajime Kayano; Tetsunosuke Shimizu; Mitsuhiro Asakuma; Fumitoshi Hirokawa; Yoshiharu Miyamoto; Atsushi Takeshita; Yuro Shibayama; Kazuhisa Uchiyama
Journal:  J Gastrointest Surg       Date:  2012-02-28       Impact factor: 3.452

Review 3.  Thermal Ablation of Metastatic Colon Cancer to the Liver.

Authors:  Juan C Camacho; Elena N Petre; Constantinos T Sofocleous
Journal:  Semin Intervent Radiol       Date:  2019-10-31       Impact factor: 1.513

4.  Perihepatic lymph node assessment in patients undergoing partial hepatectomy for malignancy.

Authors:  Stephen R Grobmyer; Liang Wang; Mithat Gonen; Yuman Fong; David Klimstra; Michael D'Angelica; Ronald P DeMatteo; Larry Schwartz; Leslie H Blumgart; William R Jarnagin
Journal:  Ann Surg       Date:  2006-08       Impact factor: 12.969

5.  Preoperative Chemotherapy May Not Influence the Remnant Liver Regenerations and Outcomes After Hepatectomy for Colorectal Liver Metastasis.

Authors:  Yoshihiro Inoue; Kensuke Fujii; Keitaro Tashiro; Masatsugu Ishii; Shinsuke Masubuchi; Masashi Yamamoto; Tetsunosuke Shimizu; Mitsuhiro Asakuma; Fumitoshi Hirokawa; Michihiro Hayashi; Yoshihumi Narumi; Kazuhisa Uchiyama
Journal:  World J Surg       Date:  2018-10       Impact factor: 3.352

6.  Proposal of criteria to select candidates with colorectal liver metastases for hepatic resection: comparison of our scoring system to the positive number of risk factors.

Authors:  Ikuo Nagashima; Tadahiro Takada; Miki Adachi; Hirokazu Nagawa; Tetsuichiro Muto; Kota Okinaga
Journal:  World J Gastroenterol       Date:  2006-10-21       Impact factor: 5.742

7.  Clinicopathological analysis of recurrence patterns and prognostic factors for survival after hepatectomy for colorectal liver metastasis.

Authors:  Michihiro Hayashi; Yoshihiro Inoue; Koji Komeda; Tetsunosuke Shimizu; Mitsuhiro Asakuma; Fumitoshi Hirokawa; Yoshiharu Miyamoto; Junji Okuda; Atsushi Takeshita; Yuro Shibayama; Nobuhiko Tanigawa
Journal:  BMC Surg       Date:  2010-09-27       Impact factor: 2.102

8.  The outcome of liver resection and lymphadenectomy for hilar lymph node involvement in colorectal cancer liver metastases.

Authors:  Wei Liu; Xiao-Luan Yan; Kun Wang; Quan Bao; Yi Sun; Bao-Cai Xing
Journal:  Int J Colorectal Dis       Date:  2014-04-18       Impact factor: 2.571

Review 9.  Detection and management of extrahepatic colorectal cancer in patients with resectable liver metastases.

Authors:  Yolanda Y L Yang; James W Fleshman; Steven M Strasberg
Journal:  J Gastrointest Surg       Date:  2007-07       Impact factor: 3.452

Review 10.  Liver metastatic disease: new concepts and biomarker panels to improve individual outcomes.

Authors:  Olga Golubnitschaja; Krishna Chander Sridhar
Journal:  Clin Exp Metastasis       Date:  2016-08-19       Impact factor: 5.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.